SPE Capital

SPE Capital is an independent investment management firm dedicated to responsible investing and consistently delivering superior returns. The firm focuses on growth equity investments, acting as a long-term strategic partner to its portfolio companies. They provide financial, strategic, and operational support, emphasizing a patient capital approach to drive both solid financial returns and positive social impact. SPE Capital primarily targets opportunities across Europe, Africa, and the Middle East, leveraging its extensive regional knowledge and on-the-ground presence.

The firm was established in 2016 as a spinout from Swicorp, a prominent regional investment banking firm. This origin provided SPE Capital with a strong foundation and an experienced team that had already invested over USD 500 million across Africa and the Middle East since 2005. The founding team brought together a wealth of expertise and a shared vision for value creation through strategic partnerships.

SPE Capital's investment portfolio spans various sectors, including notable companies such as Orchidia Pharmaceutical Industries, a leading ophthalmic pharmaceutical manufacturer in Egypt, Africa, and the Middle East. Other key investments include Ademat, a provider of power security solutions in Côte d'Ivoire; GlobalCorp, a non-banking financial services company in Egypt; Vital, a nutritional supplements producer in Tunisia; and Clinique Tilila, a multidisciplinary private clinic in Morocco. The firm also shows interest in emerging technologies, as evidenced by its insights on Artificial Intelligence in emerging markets' private equity.

The firm is led by an experienced senior team of over 20 members, boasting nearly 100 years of combined experience in the private equity sector. This team is characterized by an entrepreneurial spirit, a commitment to excellence, and a 'boots-on-the-ground' approach, working closely with partners. Key team members, such as Edouard Pontet, Managing Partner and COO, bring extensive experience in private equity across emerging markets and a background in international law, overseeing critical operational functions including finance, legal, investor engagement, and ESG.